Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

DarioHealth Corp

DRIO
Current price
0.70 USD +0.01 USD (+1.45%)
Last closed 0.69 USD
ISIN US23725P2092
Sector Healthcare
Industry Health Information Services
Exchange NASDAQ
Capitalization 24 003 866 USD
Yield for 12 month -53.02 %
1Y
3Y
5Y
10Y
15Y
DRIO
21.11.2021 - 28.11.2021

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Address: 122 W 57th St,, New York, NY, United States, 10019

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.50 USD

P/E ratio

Dividend Yield

Current Year

+20 352 000 USD

Last Year

+27 656 000 USD

Current Quarter

+7 423 000 USD

Last Quarter

+6 255 000 USD

Current Year

+5 984 000 USD

Last Year

+9 655 000 USD

Current Quarter

+3 877 000 USD

Last Quarter

+2 756 000 USD

Key Figures DRIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -53 551 000 USD
Operating Margin TTM -162.06 %
Price to Earnings
Return On Assets TTM -34.74 %
PEG Ratio
Return On Equity TTM -74.91 %
Wall Street Target Price 3.50 USD
Revenue TTM 23 052 000 USD
Book Value 1.87 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 111.00 %
Dividend Yield
Gross Profit TTM 14 012 000 USD
Earnings per share -0.93 USD
Diluted Eps TTM -0.93 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -205.62 %

Dividend Analytics DRIO

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History DRIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:20
Payout Ratio
Last Split Date 18.11.2019

Stock Valuation DRIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.73
Price Sales TTM 1.04
Enterprise Value EBITDA -0.59
Price Book MRQ 0.43

Financials DRIO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DRIO

For 52 weeks

0.66 USD 2.60 USD
50 Day MA 0.89 USD
Shares Short Prior Month 1 924 894
200 Day MA 1.17 USD
Short Ratio 19.96
Shares Short 1 907 621
Short Percent 6.22 %
Dividend information is being updated